» Authors » Amanda M Termuhlen

Amanda M Termuhlen

Explore the profile of Amanda M Termuhlen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 644
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Weil B, Murphy A, Liu Q, Howell R, Smith S, Weldon C, et al.
J Clin Oncol . 2023 Jan; 41(14):2638-2650. PMID: 36693221
Purpose: To evaluate long-term morbidity and mortality among unilateral, nonsyndromic Wilms tumor (WT) survivors according to conventional treatment regimens. Methods: Cumulative incidence of late mortality (≥ 5 years from diagnosis)...
2.
Logeais M, Eckerstorfer M, Krohn K, Everson-Rose S, Termuhlen A, Joseph A
Acad Med . 2022 Jul; 97(12):1816-1823. PMID: 35794809
Purpose: Women remain underrepresented in key leadership positions and advanced ranks in academic medicine. This study examines the numbers of men and women letter writers for promotion candidates during a...
3.
Dietz A, Seidel K, Leisenring W, Mulrooney D, Tersak J, Glick R, et al.
Lancet Oncol . 2019 Sep; 20(10):1420-1431. PMID: 31471158
Background: Serious chronic medical conditions occur in childhood cancer survivors. We aimed to investigate incidence of and risk factors for end-organ damage resulting in registration on a waiting list for...
4.
Chu Y, Gardenswartz A, Termuhlen A, Cairo M
Br J Haematol . 2019 Jan; 185(6):1055-1070. PMID: 30613939
Patients with relapsed, refractory or advanced stage B non-Hodgkin lymphoma (NHL) continue to have a dismal prognosis. This review summarises current and novel cellular and immunotherapy for these high-risk populations,...
5.
Termuhlen A
Clin Adv Hematol Oncol . 2017 Apr; 15(3):200-209. PMID: 28398275
Natural killer/T-cell (NK/T-cell) lymphomas are rare in children and adolescents and consist predominantly of nasal-type extranodal NK/T-cell lymphomas. More than half of pediatric/adolescent patients with NK/T-cell lymphomas present with localized...
6.
Landier W, Hageman L, Chen Y, Kornegay N, Evans W, Bostrom B, et al.
J Clin Oncol . 2017 Mar; 35(15):1730-1736. PMID: 28339328
Purpose Children with acute lymphoblastic leukemia (ALL) are generally instructed to take mercaptopurine (6-MP) in the evening and without food or dairy products. This study examines the association between 6-MP...
7.
Landier W, Chen Y, Hageman L, Kim H, Bostrom B, Casillas J, et al.
Blood . 2017 Feb; 129(14):1919-1926. PMID: 28153823
Adequate exposure to oral 6-mercaptopurine (6MP) during maintenance therapy for childhood acute lymphoblastic leukemia (ALL) is critical for sustaining durable remissions; accuracy of self-reported 6MP intake is unknown. We aimed...
8.
Meyer J, Zhou D, Mason C, Downie J, Rodic V, Abromowitch M, et al.
Pediatr Blood Cancer . 2016 Dec; 64(7). PMID: 27957801
Background: Recurrent genomic changes in B-lymphoblastic leukemia (B-ALL) identified by genome-wide single-nucleotide polymorphism (SNP) microarray analysis provide important prognostic information, but gene copy number analysis of its rare lymphoma counterpart,...
9.
de Smith A, Ojha J, Francis S, Sanders E, Endicott A, Hansen H, et al.
Oncotarget . 2016 Sep; 7(45):72733-72745. PMID: 27683039
High hyperdiploidy (HD), the most common cytogenetic subtype of B-cell acute lymphoblastic leukemia (B-ALL), is largely curable but significant treatment-related morbidity warrants investigating the biology and identifying novel drug targets....
10.
Richardson P, Riches M, Kernan N, Brochstein J, Mineishi S, Termuhlen A, et al.
Blood . 2016 Jan; 127(13):1656-65. PMID: 26825712
Hepatic veno-occlusive disease (VOD), also called sinusoidal obstruction syndrome (SOS), is a potentially life-threatening complication of hematopoietic stem cell transplantation (HSCT). Untreated hepatic VOD/SOS with multi-organ failure (MOF) is associated...